Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-462829
Filing Date
2012-11-09
Accepted
2012-11-09 14:13:42
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d402747d10q.htm 10-Q 414467
2 EMPLOYMENT AGREEMENT d402747dex103.htm EX-10.3 95519
3 CERTIFICATION PURSUANT TO RULE 13A-14(A) d402747dex311.htm EX-31.1 10394
4 CERTIFICATION PURSUANT TO RULE 13A-14(A) d402747dex312.htm EX-31.2 10398
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d402747dex321.htm EX-32.1 5154
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d402747dex322.htm EX-32.2 5158
  Complete submission text file 0001193125-12-462829.txt   3464128

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT galt-20120930.xml EX-101.INS 345386
8 XBRL TAXONOMY EXTENSION SCHEMA galt-20120930.xsd EX-101.SCH 42630
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20120930_cal.xml EX-101.CAL 38881
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20120930_def.xml EX-101.DEF 222480
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20120930_lab.xml EX-101.LAB 318895
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20120930_pre.xml EX-101.PRE 262203
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 121192999
SIC: 2834 Pharmaceutical Preparations